News All News Click here to be updated on news from StarkAge Therapeutics All CorporateJob Offer Posted on Tuesday, May 10, 2022Tuesday, May 10, 2022 Categories Corporate Starkage Therapeutics appoints Benjamin Le Calvé as CSO ... Posted on Thursday, February 24, 2022Sunday, April 10, 2022 Categories Job Offer StarkAge Therapeutics seeks their Chief Scientific Officer (CSO) based in Lille, France ... Posted on Sunday, February 13, 2022Thursday, February 24, 2022 Categories Corporate StarkAge Therapeutics establishes its Scientific Advisor Board of international independent experts and holds their foundational meeting ... Posted on Tuesday, January 18, 2022Sunday, February 13, 2022 Categories Corporate StarkAge Therapeutics awarded €2m from BPI France to develop innovative immunotherapy approach targeting senescent cells in age-related diseases ...
Posted on Tuesday, May 10, 2022Tuesday, May 10, 2022 Categories Corporate Starkage Therapeutics appoints Benjamin Le Calvé as CSO ...
Posted on Thursday, February 24, 2022Sunday, April 10, 2022 Categories Job Offer StarkAge Therapeutics seeks their Chief Scientific Officer (CSO) based in Lille, France ...
Posted on Sunday, February 13, 2022Thursday, February 24, 2022 Categories Corporate StarkAge Therapeutics establishes its Scientific Advisor Board of international independent experts and holds their foundational meeting ...
Posted on Tuesday, January 18, 2022Sunday, February 13, 2022 Categories Corporate StarkAge Therapeutics awarded €2m from BPI France to develop innovative immunotherapy approach targeting senescent cells in age-related diseases ...
